Thyroid cancer

Publishing Date : August, 2015
Report Code : HCOC111
Price:
Single license $4,500
Site license $6,300
Global license $7,200

“Thyroid Cancer Pipeline Analysis” report gives comprehensive insight on various drugs being developed for the treatment of Thyroid Cancer. The report discusses the unmet needs and strategies to overcome those. Also, covers some of the hot targets in research for treatment.

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative opportunities in the thyroid cancer market. The report also provides strategic insights on medicines that are likely to have an impact on thyroids cancer treatment space and potentially alter standards of care in the foreseeable future. This helps in identifying the Best-in-class & First-in-class drugs.

Some of the key sections of report are given below:

Epidemiology

In this section, thyroid cancer epidemiology is covered to understand the potential significance and impact of the thyroid Cancer.

  • Global prevalence & incidence rate based-on age groups and gender

Market analysis

In this section, global drugs market would be covered region-wise along with the CAGRs.

  • Forecasting model for market
  • Market dynamics
  • Global and regional drugs market

Pipeline Analysis

Pipeline analysis sections provides deeper insights on various drugs in discovery & development, pipelines from major companies would be covered along with potential targets, mechanism of action, Current development status.

  • Pipeline analysis by developmental stage
  • Pipeline analysis by leading players
  • Pipeline analysis by targets & mechanism of action
  • IP status

Key Players Analysis

The key player’s analysis section provides an in-depth understanding of various companies working on thyroid cancer in focus and their pipelines with development phase as well as understanding partnering strategies such as deals entered by the company.

  • Global key players overview
  • Global key players pipeline data
  • Global key players deal (collaborations, licensing, service agreements, grants, funds etc.)  
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     HIGH DEMAND FOR CUSTOMIZATION
        • 3.3.1.2     INCREASING DEMAND FOR IMPLANTS IN HEALTHCARE INDUSTRY
        • 3.3.1.3     HIGH INVESTMENT IN R&D FROM NEW ENTRANT
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST OF 3D PRINTERS
        • 3.3.2.2     LIMITED TYPE OF MATERIAL AVAILABILITY
        • 3.3.2.3     STRINGENT REGULATIONS FOR 3D PRINTED MEDICAL DEVICE APPROVAL
        • 3.3.2.4     PATENT INFRINGEMENT
      • 3.3.3     CHALLENGES
        • 3.3.3.1     REIMBURSEMENT ISSUES
    • 3.4     PATENT ANALYSIS
    • 3.5     3D PRINTING SUPPLY CHAIN ANALYSIS
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.6.4     BARGAINING POWER OF SUPPLIERS
      • 3.6.5     BARGAINING POWER OF BUYERS
    • 3.7     REGULATORY AFFAIRS
      • 3.7.1     UNITED STATES
      • 3.7.2     EUROPE
      • 3.7.3     SOUTH KOREA
      • 3.7.4     CHINA
      • 3.7.5     JAPAN
      • 3.7.6     INDIA
    • 3.8     MARKET SHARE ANALYSIS
    • 3.9     RECENT TREND BASED-ON APPLICATION
    • 3.10     UPCOMING TRENDS
  • 4     3D PRINTING HEALTHCARE GLOBAL MARKET, BY CATEGORY
    • 4.1     INTRODUCTION
    • 4.2     PRODUCTS
    • 4.3     SERVICES
    • 4.4     MATERIALS
      • 4.4.1     METAL
      • 4.4.2     POLYMER
      • 4.4.3     CERAMIC
      • 4.4.4     OTHERS (DONOR CELL & PHARMACEUTICAL MATERIAL)
  • 5     3D PRINTING HEALTHCARE GLOBAL MARKET, BY PROCESS
    • 5.1     INTRODUCTION
    • 5.2     PHOTOPOLYMERIZATION
      • 5.2.1     STEREOLITHOGRAPHY
      • 5.2.2     DIGITAL LIGHT PROCESSING
      • 5.2.3     TWO PHOTON POLYMERIZATION
    • 5.3     DEPOSITION
      • 5.3.1     FUSED DEPOSITION MODELING (FDM)
      • 5.3.2     EXTRUSION BIOPRINTING
    • 5.4     FUSION
      • 5.4.1     SELECTIVE LASER SINTERING
      • 5.4.2     DIRECT METAL LASER SINTERING
      • 5.4.3     SELECTIVE LASER MELTING
      • 5.4.4     ELECTRON BEAM MELTING
      • 5.4.5     LASER-ASSISTED BIOPRINTING
    • 5.5     JETTING
      • 5.5.1     MULTIPHASE JET SOLIDIFICATION (MJS)
      • 5.5.2     BINDER JETTING
        • 5.5.2.1     ZIPDOSE TECHNOLOGY
      • 5.5.3     INKJET-BASED BIOPRINTING
  • 6     3D PRINTING HEALTHCARE GLOBAL MARKET, BY APPLICATION
    • 6.1     INTRODUCTION
    • 6.2     IMPLANTS & PROSTHETICS
      • 6.2.1     DENTAL IMPLANTS
      • 6.2.2     HEARING AIDS
      • 6.2.3     ORTHOPEDIC IMPLANTS
      • 6.2.4     OTHERS
        • 6.2.4.1     STENTS
        • 6.2.4.2     CATHETERS
    • 6.3     TISSUE ENGINEERING
    • 6.4     SURGICAL INSTRUMENTS
    • 6.5     SURGICAL GUIDES
    • 6.6     PHARMACEUTICAL APPLICATIONS
  • 7     3D PRINTING HEALTHCARE GLOBAL MARKET, BY END USERS
    • 7.1     INTRODUCTION
    • 7.2     HOSPITALS
    • 7.3     BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
    • 7.4     ACADEMIC INSTITUTES
    • 7.5     OTHERS
  • 8     3 D PRINTING HEALTHCARE GLOBAL MARKET, BY GEOGRAPHY
    • 8.1     INTRODUCTION
    • 8.2     NORTH AMERICA
    • 8.3     EUROPE
    • 8.4     ASIA PACIFIC
    • 8.5     REST OF THE WORLD
  • 9     COMPETITIVE LANDSCAPE
    • 9.1     INTRODUCTION
    • 9.2     NEW PRODUCT LAUNCHES
    • 9.3     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
    • 9.4     EXPANSIONS, APPOVALS AND SERVICE LAUNCHES
  • 10     COMPANY PROFILES

    LIST OF TABLES

    LIST OF FIGURES

    LIST OF COMPANIES MENTIONED IN THE REPORT

    • 10.1     3D SYSTEMS
      • 10.1.1     OVERVIEW
      • 10.1.2     FINANCIALS
      • 10.1.3     PRODUCT PORTFOLIO
      • 10.1.4     KEY DEVELOPMENTS
      • 10.1.5     BUSINESS STRATEGY
      • 10.1.6     SWOT ANALYSIS
    • 10.2     ARCAM AB
      • 10.2.1     OVERVIEW
      • 10.2.2     FINANCIALS
      • 10.2.3     PRODUCT PORTFOLIO
      • 10.2.4     KEY DEVELOPMENTS
      • 10.2.5     BUSINESS STRATEGY
      • 10.2.6     SWOT ANALYSIS
    • 10.3     EOS
      • 10.3.1     OVERVIEW
      • 10.3.2     FINANCIALS
      • 10.3.3     PRODUCT PORTFOLIO
      • 10.3.4     KEY DEVELOPMENTS
      • 10.3.5     BUSINESS STRATEGY
      • 10.3.6     SWOT ANALYSIS
    • 10.4     ENVISIONTEC
      • 10.4.1     OVERVIEW
      • 10.4.2     FINANCIALS
      • 10.4.3     PRODUCT PORTFOLIO
      • 10.4.4     KEY DEVELOPMENTS
      • 10.4.5     BUSINESS STRATEGY
      • 10.4.6     SWOT ANALYSIS
    • 10.5     MATERIALISE NV
      • 10.5.1     OVERVIEW
      • 10.5.2     FINANCIALS
      • 10.5.3     PRODUCT PORTFOLIO
      • 10.5.4     KEY DEVELOPMENTS
      • 10.5.5     BUSINESS STRATEGY
      • 10.5.6     SWOT ANALYSIS
    • 10.6     NANO 3D BIOSCIENCES, INC
      • 10.6.1     OVERVIEW
      • 10.6.2     FINANCIALS
      • 10.6.3     PRODUCT PORTFOLIO
      • 10.6.4     KEY DEVELOPMENTS
      • 10.6.5     BUSINESS STRATEGY
      • 10.6.6     SWOT ANALYSIS
    • 10.7     ORGANOVO
      • 10.7.1     OVERVIEW
      • 10.7.2     FINANCIALS
      • 10.7.3     PRODUCT PORTFOLIO
      • 10.7.4     KEY DEVELOPMENTS
      • 10.7.5     BUSINESS STRATEGY
      • 10.7.6     SWOT ANALYSIS
    • 10.8     OPTOMEC
      • 10.8.1     OVERVIEW
      • 10.8.2     FINANCIALS
      • 10.8.3     PRODUCT PORTFOLIO
      • 10.8.4     KEY DEVELOPMENTS
      • 10.8.5     BUSINESS STRATEGY
      • 10.8.6     SWOT ANALYSIS
    • 10.9     RENISHAW
      • 10.9.1     OVERVIEW
      • 10.9.2     FINANCIALS
      • 10.9.3     PRODUCT PORTFOLIO
      • 10.9.4     KEY DEVELOPMENTS
      • 10.9.5     BUSINESS STRATEGY
      • 10.9.6     SWOT ANALYSIS
    • 10.10     STRATASYS
      • 10.10.1     OVERVIEW
      • 10.10.2     FINANCIALS
      • 10.10.3     PRODUCT PORTFOLIO
      • 10.10.4     KEY DEVELOPMENTS
      • 10.10.5     BUSINESS STRATEGY
      • 10.10.6     SWOT ANALYSIS
      • TABLE 1     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 2     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY CATEGORY, (2014-2022) ($MN)
      • TABLE 3     3D PRINTING HEALTHCARE PRODUCTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 4     3D PRINTING HEALTHCARE SERVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 5     3D PRINTING HEALTHCARE MATERIAL GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 6     METAL MATERIAL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 7     POLYMER MATERIAL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 8     CERAMIC MATERIAL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 9     OTHER MATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 10     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 11     PHOTOPOLYMERISATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 12     PHOTOPOLYMERISATION GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 13     STEREOLITHOGRAPHY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 14     DIGITAL LIGHT PROCESSING (DLP) TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 15     TWO-PHOTON POLYMERIZATION (2PP) TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 16     DEPOSITION PROCESS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 17     DEPOSITION PROCESS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 18     FUSED DEPOSITION MODELLING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 19     EXTRUSION BIO-PRINTING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 20     FUSION PROCESS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 21     FUSION PROCESS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 22     SELECTIVE LASER SINTERING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 23     DIRECT METAL LASER SINTERING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 24     SELECTIVE LASER MELTING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 25     ELECTRON BEAM MELTING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 26     LASER-ASSISTED BIOPRINTING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 27     JETTING PROCESS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 28     JETTING PROCESS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 29     MULTIJET/POLYJET TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 30     BINDER JETTING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 31     INK JET-BASED BIOPRINTING TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 32     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 33     IMPLANTS & PROSTHETICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 34     IMPLANTS & PROSTHETICS 3D PRINTING HEALTHCARE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 35     DENTAL 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 36     HEARING AIDS 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 37     ORTHOPEDICS 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 38     OTHERS 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 39     TISSUE ENGINEERING 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 40     SURGICAL INSTRUMENTS 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 41     SURGICAL GUIDES 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 42     PHARMACEUTICAL APPLICATIONS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 43     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 44     HOSPITALS 3D-PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 45     BIOTECH & PHARMA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 46     ACADEMIC INSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 47     OTHERS (CRO’S) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 48     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 49     NORTH AMERICAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 50     NORTH AMERICAN PHOTOPOLYMERISATION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 51     NORTH AMERICAN DEPOSITION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 52     NORTH AMERICAN FUSION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 53     NORTH AMERICAN JETTING 3D PRINTING HEALTHCARE MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 54     NORTH AMERICAN 3D PRINTING HEALTHCARE MATERIAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 55     NORTH AMERICAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 56     NORTH AMERICAN IMPLANTS & PROSTHETICS 3D PRINTING HEALTHCARE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 57     NORTH AMERICAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 58     NORTH AMERICAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY CATEGORY, (2014-2022) ($MN)
      • TABLE 59     EUROPEAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 60     EUROPEAN PHOTOPOLYMERIZATION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 61     EUROPEAN DEPOSITION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 62     EUROPEAN FUSION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 63     EUROPEAN JETTING PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 64     EUROPEAN 3D PRINTING HEALTHCARE MATERIAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 65     EUROPEAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 66     EUROPEAN IMPLANTS & PROSTHETICS 3D PRINTING HEALTHCARE MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 67     EUROPEAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 68     EUROPEAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY CATEGORY, (2014-2022) ($MN)
      • TABLE 69     ASIA-PACIFIC 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 70     ASIA-PACIFIC PHOTOPOLYMERIZATION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 71     ASIA-PACIFIC DEPOSITION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 72     ASIA-PACIFIC FUSION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 73     ASIA-PACIFIC JETTING PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 74     ASIA-PACIFIC 3D PRINTING HEALTHCARE MATERIAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 75     ASIA-PACIFIC 3D PRINTING HEALTHCARE MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 76     ASIA-PACIFIC IMPLANTS & PROSTHETICS 3D MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 77     ASIA-PACIFIC 3D PRINTING HEALTHCARE MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 78     ASIA-PACIFIC 3D PRINTING HEALTHCARE MARKET REVENUE, BY CATEGORY, (2014-2022) ($MN)
      • TABLE 79     ROW 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 80     ROW PHOTOPOLYMERIZATION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 81     ROW DEPOSITION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 82     ROW FUSION PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 83     ROW JETTING PROCESS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
      • TABLE 84     ROW 3D PRINTING HEALTHCARE MATERIAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 85     ROW 3D PRINTING HEALTHCARE MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 86     ROW IMPLANTS & PROSTHETIC MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 87     ROW 3D PRINTING HEALTHCARE MARKET REVENUE, BY END-USER, (2014-2022) ($MN)
      • TABLE 88     ROW 3D PRINTING HEALTHCARE MARKET REVENUE, BY CATEGORY, (2014-2022) ($MN)
      • TABLE 89     NEW PRODUCT LAUNCHES (2013-2015)
      • TABLE 90     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2013-2015)
      • TABLE 91     EXPANSIONS AND APPROVALS (2013-2015)
      • TABLE 92     3D SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 93     3D SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 94     3D SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 95     ARCAM AB: TOTAL SALES AND R&D EXPENSES (2013-2015) ($MN)
      • TABLE 96     ARCAM AB: TOTAL SALES, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 97     ARCAM AB: TOTAL SALES, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 98     ORGANOVO: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 99     RENISHAW: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 100     RENISHAW: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 101     RENISHAW: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 102     STRATASYS: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 103     STRATASYS: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 104     STRATASYS: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • FIGURE 1     GLOBAL 3D PRINTING HEALTHCARE MARKET SHARE AND REVENUE, BY REGION, (2014-2022)
      • FIGURE 2     3D PRINTING HEALTHCARE GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     3D PRINTING HEALTHCARE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     3D PRINTING HEALTHCARE GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     3D PRINTING HEALTHCARE GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     3D PRINTING HEALTHCARE GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     3D PRINTING HEALTHCARE GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 9     3D PRINTING HEALTHCARE : PCT APPLICATION FILLING BY PROCESS, (2011-2016)
      • FIGURE 10     3D PRINTING HEALTHCARE PROCESS: PCT APPLICATION FILLING BY TECHNOLOGY, (2011-2016)
      • FIGURE 11     3D PRINTING HEALTHCARE GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 12     GLOBAL 3D PRINTING HEALTHCARE MARKET SHARE ANALYSIS BY KEY PLAYER, 2015 (%)
      • FIGURE 13     3D PRINTING HEALTHCARE MATERIAL GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 14     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY PROCESS, (2015 V’S 2022) ($MN)
      • FIGURE 15     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY PROCESS, (2015) ($MN)
      • FIGURE 16     3D PRINTING HEALTHCARE DEPOSITION GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015 V’S 2022) ($MN)
      • FIGURE 17     3D PRINTING HEALTHCARE FUSION GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015 V’S 2022) ($MN)
      • FIGURE 18     3D PRINTING HEALTHCARE JETING PROCESS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015 V’S 2022) ($MN)
      • FIGURE 19     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • FIGURE 20     3D PRINTING HEALTHCARE GLOBAL MARKET REVENUE, BY END-USER, (2015 V’S 2022) ($MN)
      • FIGURE 21     GLOBAL 3D-PRINTING HEALTHCARE MARKET REVENUE, BY REGION, (2014-2022) ($MN) (% CAGR)
      • FIGURE 22     NORTH AMERICAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, CATEGORY, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
      • FIGURE 23     EUROPEAN 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, CATEGORY, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
      • FIGURE 24     ASIA PACIFIC 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, CATEGORY, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
      • FIGURE 25     REST OF THE WORLD 3D PRINTING HEALTHCARE MARKET REVENUE, BY PROCESS, CATEGORY, APPLICATION & END-USER, (2015 V’S 2022) ($MN)
      • FIGURE 26     KEY GROWTH STRATEGIES, (2013 – 2015)
      • FIGURE 27     SWOT: 3D SYSTEMS
      • FIGURE 28     SWOT: ARCAM AB
      • FIGURE 29     SWOT: EOS
      • FIGURE 30     SWOT: ENVISIONTEC
      • FIGURE 31     SWOT: MATERIALISE N.V.
      • FIGURE 32     SWOT: NANO 3D BIOSCIENCES
      • FIGURE 33     SWOT: ORGANOVO
      • FIGURE 34     SWOT: OPTOMEC
      • FIGURE 35     SWOT: RENISHAW
      • FIGURE 36     SWOT: STRATASYS
      • 1     3D BIOPRINTING SOLUTIONS
      • 2     3D SYSTEMS
      • 3     ADAPTIVE 3D
      • 4     ADDITIVELY AG
      • 5     ADVANCED PROTOTYPE
      • 6     AK MEDICAL
      • 7     APRECIA PHARMACEUTICALS
      • 8     ARCAM AB
      • 9     ASPECT BIOSYSTEMS
      • 10     ATOMIC FILAMENT
      • 11     BIOBOTS
      • 12     BOTFEEDER
      • 13     CAE HEALTHCARE
      • 14     CAMPLEX
      • 15     CELLINK
      • 16     CONFIRMIS
      • 17     CYFUSE BIOMEDICAL
      • 18     DIMENSION POLYMERS
      • 19     EASTMAN 3D SOLUTIONS
      • 20     EMBODY ORTHOPEDIC LIMITED
      • 21     ENVISIONTEC
      • 22     EOS
      • 23     EXONE
      • 24     FIT PRODUCTION
      • 25     FORMLABS
      • 26     IMAGINARIUM
      • 27     INDEIGOGO
      • 28     LAYERWISE
      • 29     MATERIALISE
      • 30     MEDSHAPE
      • 31     MIMEDIS AG
      • 32     MOBELIFE
      • 33     MORGAN ADVANCED CERAMICS
      • 34     MORGAN ELECTRO CERAMICS
      • 35     MORGAN TECHNICAL CERAMICS
      • 36     NANOSCRIBE GMBH
      • 37     NATUREWORKS
      • 38     NOVABEANS
      • 39     OPTOMEC
      • 40     ORGANOVO
      • 41     OXFORD PERFORMANCE MATERIALS
      • 42     PANDORAM TECHNOLOGIES
      • 43     PHONAX
      • 44     POIETIS
      • 45     PRINTELIZE
      • 46     RAPID 3D
      • 47     RENISHAW
      • 48     REVOTEK
      • 49     ROKIT
      • 50     ROOSTERBIO
      • 51     SCULPTEO
      • 52     SHAPEWAYS
      • 53     SIRONA
      • 54     SKINPRINT
      • 55     SLM SOLUTIONS
      • 56     SONOVA
      • 57     STRATASYS
      • 58     TETRA
      • 59     TEVIDO BIODEVICES
      • 60     TEXAS INSTRUMENTS
      • 61     THINK3D
      • 62     TISSUE REGENERATION SYSTEM
      • 63     VETCT
      • 64     WHITECLOUDS
      • 65     WORREL DESIGN